🏛️ Verified NIH Record • Updated 2026-08-11

The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study (NCT05409976)

Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction

🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: W.L.Gore & Associates

🩺 Plain-English Summary (8th-Grade Level)

This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.

Who can join: Review the eligibility criteria below.

Location: Stanford University School of Medicine — Stanford, California

Age range: 18 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (17 Sites)

  • Stanford University School of Medicine — Stanford, California
  • MedStar Washington Hospital Center — Washington D.C., District of Columbia
  • Northwestern — Chicago, Illinois
  • University of Michigan — Ann Arbor, Michigan
  • Mount Sinai Medical Center — New York, New York
  • Weill Cornell Medical College — New York, New York
  • Atrium Health-Sanger Heart and Vascular Institute — Charlotte, North Carolina
  • Sentara — Norfolk, Virginia
  • Flinders Medical Centre — Adelaide, South Australia
  • Universitätsklinikum Aachen — Aachen,
  • Alexianer Klinikum Hochsauerland GmbH — Arnsberg,
  • University College Hospital GALWAY /Clinical Research Facility Galway — Galway, Connacht
  • Ospedale San Raffaele — Milan,
  • Hesperia Hospital — Modena,
  • Auckland City Hospital — Auckland,
  • Addenbrooke's Hospital — Cambridge,
  • St Thomas' Hospital — London,

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Venous Thromboses

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗